Market
Issues
McGuff Pharmaceuticals, Inc. (MPI)
recognizes that the pharmaceutical manufacturing industry is
frequently renewing itself as new technologies come on-line and the
regulatory environment adjusts to accept the technology. It is
incumbent upon MPI to skillfully combine strategic considerations with
tactical excellence to assure quick and effective market entry of new
products.
Results-Driven Solutions
MPI is committed to
identify opportunities for improvement. Close relationships with
customers, vendors and employees help us identify areas that need
change and to create results-driven solutions to satisfy those needs.
MPI will transform ourselves today, to meet the needs of tomorrow
through the proper application of technology and infrastructure.
Research & Development
MPI places a high priority on research
and development by aggressively seeking new ANDAs, and NDA’s for a
continual flow of new products. This program has resulted in numerous
achievements, including significant advances in formulation research,
process development, and pilot batch manufacturing. Improvements are
driven by performance, regulatory and user satisfaction measures.
|
|
Innovation
Change is inevitable.
MPI employs highly trained multi-disciplinary professionals that
continuously examine potential new technologies, quality systems and
business plans to ensure development of new and innovative processes.
MPI will meet emerging needs while we maintain our tradition of
quality and core competency in regulatory
affairs.
Facility Expansion
MPI will ensure that manufacturing
space and equipment are available to support our strategic growth
plan. Implementation of new designs and the execution of facility
construction is coordinated in agreement with the development of new
company goals.
 Return
to MPI Home Page |
|
